(Q33368785)
Statements
1 reference
Full-dose 90Y ibritumomab tiuxetan therapy is safe in patients with prior myeloablative chemotherapy (English)
1 reference
Samuel A Jacobs
1 reference
Nicholas Vidnovic
1 reference
Judith Joyce
1 reference
Barry McCook
1 reference
Frank Torok
1 reference
Norbert Avril
1 reference
1 October 2005
1 reference
1 reference
11
1 reference
19 Pt 2
1 reference
7146s-7150s
1 reference
Identifiers
1 reference
1 reference